文献速递糖尿病

T波异常与糖尿病患者主要心血管事件的相关性:ACCORD试验

Association of T-wave abnormalities with major cardiovascular events in diabetes: the ACCORD trial.
PubMed 文献 · Diabetologia · 2021-01-08

在ACCORD试验8176例糖尿病患者中,T波异常与全因死亡、心血管死亡、心力衰竭和主要冠心病风险升高相关,但与卒中无关;将T波异常加入UKPDS风险引擎可改善冠心病事件的风险区分与重分类,尤其在已有心血管疾病者中更明显。

要点

  • T波异常与糖尿病患者全因死亡和心血管死亡风险升高独立相关。
  • T波异常与心力衰竭和主要冠心病风险升高相关,但与卒中无关。
  • T波异常加入UKPDS风险引擎可改善已有心血管疾病者的风险区分与重分类。

核心结论

  • T波异常的存在与幅度与糖尿病患者临床心血管事件和死亡风险升高相关,可能有助于细化风险,尤其在已有心血管疾病者中。

研究设计与样本

  • 基于ACCORD试验的事后分析,纳入8176例符合条件的糖尿病患者,平均年龄62.1±6.3岁,男性占61.4%。
  • T波异常定义为任何导联分布中出现Minnesota编码5-1至5-4中的任意一项。
  • 采用多变量Cox比例风险模型分析T波异常与临床心血管事件的关系。

主要发现

  • 共发生3759例心血管事件,包括1430例死亡(其中心血管病因473例)、474例心力衰竭事件、1452例主要冠心病事件和403例卒中。
  • T波异常与全因死亡风险升高相关(HR 1.45 [95%CI 1.30, 1.62],p<0.0001)。
  • T波异常与心血管死亡风险升高相关(HR 1.93 [95%CI 1.59, 2.34],p=0.0001)。
  • T波异常与充血性心力衰竭风险升高相关(HR 2.04 [95%CI 1.69, 2.48],p<0.0001)和主要冠心病风险升高相关(HR 1.40 [95%CI 1.26, 1.57],p<0.0001)。
  • T波异常与卒中风险无显著相关(HR 0.99 [95%CI 0.80, 1.23],p=0.95)。

关键数值与推荐

  • 将T波异常加入UKPDS风险引擎后,对 incident CHD事件的区分能力改善仅见于已有心血管疾病者(AUC 0.5744 vs 0.6030,p=0.0067)。
  • 重分类改善在已有心血管疾病者中更大(NRI 0.24 [95%CI 0.16, 0.32]),无心血管疾病者为NRI 0.14 [95%CI 0.07, 0.22]。

临床怎么用

  • 在糖尿病患者中,心电图T波异常可提示心血管事件和死亡风险升高,尤其需关注心力衰竭和冠心病风险。
  • 对于已有心血管疾病的糖尿病患者,T波异常可能有助于进一步细化冠心病风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: T-wave abnormalities (TWA) are often found on ECG and signify abnormal ventricular repolarisation. While TWA have been shown to be associated with subclinical atherosclerosis, the relationship between TWA and hard cardiovascular endpoints is less clear and may differ in the presence of diabetes, so we sought to explore these associations in participants from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. METHODS: TWA were operationally defined as the presence of any Minnesota Codes 5-1 through 5-4 in any lead distribution. Multivariable Cox proportional hazards models were constructed to examine relationships between TWA and clinical cardiovascular events. Secondary analyses explored the risks conferred by major vs minor TWA, differential effects of TWA by anatomic localisation (anterolateral, inferior or anterior lead distributions), and differing associations in those with or without prevalent CVD. RESULTS: Among 8176 eligible participants (mean 62.1 ± 6.3 SD years, 61.4% male), there were 3759 cardiovascular events, including 1430 deaths (473 of a cardiovascular aetiology), 474 heart failure events, 1452 major CHD events and 403 strokes. Participants with TWA had increased risks of all-cause mortality (HR 1.45 [95% CI 1.30, 1.62], p < 0.0001), cardiovascular mortality (HR 1.93 [1.59, 2.34], p = 0.0001), congestive heart failure (HR 2.04 [1.69, 2.48], p < 0.0001) and major CHD (HR 1.40 [1.26, 1.57], p < 0.0001), but no increased risk of stroke (HR 0.99 [0.80, 1.23], p = 0.95). Major TWA conferred a higher risk than minor TWA. When TWA were added to the UK Prospective Diabetes Study risk engine, there was improved discrimination for incident CHD events, but only for those with prevalent CVD (area under the receiver operating characteristic curve 0.5744 and 0.6030 with p = 0.0067). Adding TWA to the risk engine yielded improvements in reclassification that were of greater magnitude in those with prevalent CVD (net reclassification improvement [NRI] 0.24 [95% CI 0.16, 0.32] in those with prevalent CVD, NRI 0.14 [95% CI 0.07, 0.22] in those without prevalent CVD). CONCLUSIONS/INTERPRETATION: The presence and magnitude of TWA are associated with increased risk of clinical cardiovascular events and mortality in individuals with diabetes and may have value in refining risk, particularly in those with prevalent CVD. Graphical abstract.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Mould SJ, Soliman EZ, Bertoni AG, et al. Association of T-wave abnormalities with major cardiovascular events in diabetes: the ACCORD trial. Diabetologia. 2021. PMID: 33420509. doi:10.1007/s00125-020-05337-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。